Shionogi & Co., Ltd. (4507)
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- 0.00
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 0.00
- Min lot size
- 0
- Currency
- --
News
- Market Beat · Sep 24 at 11:00 PM
Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Update
- Simplywall · Sep 17 at 10:08 PM
Shionogi (TSE:4507) Wins New Drug Approvals On Questions Over Whether The Value Case Still Holds
- Fiercepharma · Sep 15 at 01:00 PM
Shionogi starts omnichannel campaign for COVID-19 pill Xocova
- Unusual Whales · Sep 15 at 12:04 PM
Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.
- Market Beat · Sep 11 at 01:20 AM
Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Grows By 797.8%
- PUBT · Sep 9 at 12:31 PM
Shionogi presents new Phase 3 SCORPIO-PEP subpopulation data on COVID-19 antiviral XOCOVA at IDWeek 2026
